These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 29574877)
1. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo. Jeng LB; Kumar Velmurugan B; Chen MC; Hsu HH; Ho TJ; Day CH; Lin YM; Padma VV; Tu CC; Huang CY J Cell Physiol; 2018 Sep; 233(9):7134-7142. PubMed ID: 29574877 [TBL] [Abstract][Full Text] [Related]
2. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model. Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870 [TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells. Su P; Yang Y; Wang G; Chen X; Ju Y Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726 [TBL] [Abstract][Full Text] [Related]
4. Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis. Chen MC; Hsu HH; Chu YY; Cheng SF; Shen CY; Lin YJ; Chen RJ; Viswanadha VP; Lin YM; Huang CY Environ Toxicol; 2018 May; 33(5):587-593. PubMed ID: 29436100 [TBL] [Abstract][Full Text] [Related]
5. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells. Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806 [TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488 [TBL] [Abstract][Full Text] [Related]
7. Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines. Zehra K; Banu A; Can E; Hülya C Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7913-7926. PubMed ID: 38748229 [TBL] [Abstract][Full Text] [Related]
8. Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status. Gaur S; Chen L; Ann V; Lin WC; Wang Y; Chang VH; Hsu NY; Shia HS; Yen Y Mol Cancer; 2014 Feb; 13():21. PubMed ID: 24495750 [TBL] [Abstract][Full Text] [Related]
9. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice. Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338 [TBL] [Abstract][Full Text] [Related]
10. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells. Liu C; Liu Q; Yan A; Chang H; Ding Y; Tao J; Qiao C Cancer Med; 2020 Jun; 9(11):3875-3884. PubMed ID: 32248666 [TBL] [Abstract][Full Text] [Related]
11. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells. Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854 [TBL] [Abstract][Full Text] [Related]
12. Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer. Khan N; Jajeh F; Eberhardt EL; Miller DD; Albrecht DM; Van Doorn R; Hruby MD; Maresh ME; Clipson L; Mukhtar H; Halberg RB Int J Cancer; 2019 Dec; 145(11):3022-3032. PubMed ID: 31018249 [TBL] [Abstract][Full Text] [Related]
13. Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab. Prewett M; Deevi DS; Bassi R; Fan F; Ellis LM; Hicklin DJ; Tonra JR Clin Cancer Res; 2007 Dec; 13(24):7432-40. PubMed ID: 18094427 [TBL] [Abstract][Full Text] [Related]
14. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan. Poorebrahim M; Sadeghi S; Ghanbarian M; Kalhor H; Mehrtash A; Teimoori-Toolabi L Cancer Chemother Pharmacol; 2020 Jan; 85(1):153-171. PubMed ID: 31781855 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway. Lin MT; Lin CL; Lin TY; Cheng CW; Yang SF; Lin CL; Wu CC; Hsieh YH; Tsai JP Tumour Biol; 2016 May; 37(5):6987-96. PubMed ID: 26662956 [TBL] [Abstract][Full Text] [Related]
16. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan. Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344 [TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells. Skarkova V; Kralova V; Krbal L; Matouskova P; Soukup J; Rudolf E Exp Cell Res; 2018 Aug; 369(2):295-303. PubMed ID: 29842879 [TBL] [Abstract][Full Text] [Related]
18. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway. Chian S; Li YY; Wang XJ; Tang XW Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924 [TBL] [Abstract][Full Text] [Related]
19. [The Antitumor Effects of Fisetin on Ovarian Cancer Meng YB; Xiao C; Chen XL; Bai P; Yao Y; Wang H; Xiao X Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):830-836. PubMed ID: 28598107 [TBL] [Abstract][Full Text] [Related]
20. The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways. Youns M; Abdel Halim Hegazy W PLoS One; 2017; 12(1):e0169335. PubMed ID: 28052097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]